Current Clinical Trial Studies

We are currently offering clinical trials in the areas shown below. For more information, just click on the name of the study. All of our clinical trials follow FDA guidelines and adhere to the standards of good clinical practice. Leading national and international medical companies serve as sponsors for all of our trials. If you decide to take part in one of our studies, you can be assured that you will receive excellent care. That is our promise to you.


Adolescent Constipation
Start Date: 5/29/2017
Enrollment Status: Closed

Ask A Question About This Study
Description:
A 14 week study on the effectiveness of plecanatide for children aged 12 to 17 years old with a diagnosis of constipation.

Disease Targeted:
Chronic Constipation in Children

Objectives:
To evaluate the safety and effectiveness of plecanatide for the treatment of chronic constipation in adolescent patients.


Diabetic Gastroparesis
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 22 week, double blind, randomized study on the safety and efficacy of Relamorelin for the treatment of gastroparesis in patients with Type I or Type II Diabetes.

Disease Targeted:
Diabetic Gastroparesis

Objectives:
To evaluate the safety and efficacy of Relamorelin in patients with diabetic gastroparesis.


Hypertension
Start Date: 10/1/2017
Enrollment Status: Closed

Ask A Question About This Study
Description:
A 38 week study the effectiveness of bexagliflozin (currently used to treat diabetes) on patients with high blood pressure.

Disease Targeted:
Hypertension

Objectives:
To evaluate the efficacy and safety of bexagliflozin in patients with hypertension that is not adequately controlled by standard of care.


Type II Diabetes
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 29 week study on the effectiveness of bexagliflozin for subjects taking metformin.

Disease Targeted:
Type II Diabetes

Objectives:
To evaluate the efficacy and safety of bexagliflozin in subjects with Type II Diabetes who are not adequately controlled by metformin alone.


High Cholesterol
Start Date: 12/28/2017
Enrollment Status: Closed

Ask A Question About This Study
Description:
An 18 month study to compare the effectiveness of Inclisiran Sodium versus placebo on low density lipoprotein cholesterol.

Disease Targeted:
Hyperlipidemia / Dyslipidemia / High Cholesterol

Objectives:
To evaluate the effect of 300mg of Inclisiran Sodium given as a subcutaneous injection in subjects with cardiovascular disease and elevated LDL.


Asthma
Start Date: 1/5/2018
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
An 18 month study for asthma patients age 12 to 80 years old.

Disease Targeted:
Asthma

Objectives:
The purpose of this study is to evaluate the efficacy and safety of Tezepelumab in adults and adolescents with asthma.


Low Testosterone
Start Date: 3/12/2018
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A phase IV, randomized, double-blind, placebo-controlled, multicenter study of topical testosterone medication in hypogonadal men with increased risk for cardiovascular disease.

Disease Targeted:
Low Testosterone

Objectives:
To compare the effect of testosterone replacement therapy and matching placebo on major cardiovascular events in men.